LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,113
تعداد مقالات10,208
تعداد مشاهده مقاله40,779,966
تعداد دریافت فایل اصل مقاله8,803,882
Jokar, Mohammad, Mirfeizi, Zahra, Keyvanpajoh, Kamran. (1393). The Effect of Alendronate on Symptoms of Knee Osteoarthritis: A Randomized Controlled Trial. سامانه مدیریت نشریات علمی, 35(1), 9-15.
Mohammad Hassan Jokar; Zahra Mirfeizi; Kamran Keyvanpajoh. "The Effect of Alendronate on Symptoms of Knee Osteoarthritis: A Randomized Controlled Trial". سامانه مدیریت نشریات علمی, 35, 1, 1393, 9-15.
Jokar, Mohammad, Mirfeizi, Zahra, Keyvanpajoh, Kamran. (1393). 'The Effect of Alendronate on Symptoms of Knee Osteoarthritis: A Randomized Controlled Trial', سامانه مدیریت نشریات علمی, 35(1), pp. 9-15.
Jokar, Mohammad, Mirfeizi, Zahra, Keyvanpajoh, Kamran. The Effect of Alendronate on Symptoms of Knee Osteoarthritis: A Randomized Controlled Trial. سامانه مدیریت نشریات علمی, 1393; 35(1): 9-15.

The Effect of Alendronate on Symptoms of Knee Osteoarthritis: A Randomized Controlled Trial

Iranian Journal of Medical Sciences
مقاله 2، دوره 35، شماره 1، خرداد 2010، صفحه 9-15    اصل مقاله (178.95 K)
نوع مقاله: Original Article(s)
نویسندگان
Mohammad Hassan Jokar* ؛ Zahra Mirfeizi؛ Kamran Keyvanpajoh
Rheumatic Diseases Research Center, Mashhad University for Medical Sciences, Mashhad, Iran.
چکیده
Background: Knee osteoarthritis is a common degenerative joint disorder and a major cause of pain and disability. Recent studies have suggested that bisphosphonates such as alendronate may have a role in the treatment of osteoarthritis. The purpose of the present study was to investigate the potential effect of alendronate on the symptoms of knee osteoarthritis. Methods: Thirty nine patients with mild to moderate knee osteoarthritis were enrolled in a randomized, double-blind, placebo-controlled trial with parallel-group design. The patients received either placebo or alendronate pills (70mg, weekly) in a blinded fashion for six months. Symptoms of osteoarthritis were scored by Western Ontario and McMaster Universities (WOMAC) osteoarthritis index at enrollment and at weeks 4, 12, and 24.Results: In both groups there was a significant improvement in total WOMAC score and WOMAC subscales scores of pain, stiffness, and function at 4, 12, and 24 weeks of treatment. Maximum improvement occurred at week 4. There was no statistically significant difference between the two groups regarding their total WOMAC score and its subscales at the end of weeks 4, 12, or 24 (P=0.94). Conclusion: Alendronate does not reduce symptoms of mild to moderate knee osteoarthritis.
کلیدواژه‌ها
Bisphosphonate؛ degenerative joint disease؛ knee؛ arthritis
آمار
تعداد مشاهده مقاله: 1,871
تعداد دریافت فایل اصل مقاله: 950


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب